BADIA HARLIN: Open Payments
NPI 1700804499 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 28 payments from 8 companies in 2025. Trend: 2023 $178 · 2024 $334 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $325 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Alkermes, Inc. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Corium, LLC | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, SPRAVATO, UZEDY, INVEGA SUSTENNA, COBENFY, Azstarys, VIVITROL, Xelstrym.
Industry payments across TX — which companies pay providers there.
